Tag: cross trial comparison

#VisualAbstract An ixazomib-based regimen may be a better-tolerated approach in elderly patients with newly diagnosed multiple myeloma

byKathleen Lau

December 18, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Leqembi gains at home injection for maintenance dosing
Computed Tomographic Angiography and Yield for Gastrointestinal Bleeding in the Emergency Department
Novo’s self replicating RNA push expands cardiometabolic pipeline

No Result

View All Result